Cardiovascular Risk Factors in Relation to Socio-Economic Status Among Patients with Type 2 Diabetes in Urmia, Iran
Purpose: To investigate the effect of socio-economic status (SES) on cardiovascular disease among type 2 diabetic patients in Urmia, Iran.
Methods: A cross-sectional study was conducted on 251 patients with type 2 diabetes referred to the Urmia Diabetes Unit over the period September-March 2010. A self-administrated questionnaire was employed for data collection. Clinical data of glycemic control and blood pressure were collected from patient records. Multiple logistic regression analysis was used to assess the effect of SES on health outcomes.
Results: Patients with a high socioeconomic status were less likely to have uncontrolled HbA1c (OR=0.87; 95 % CI; 0.79-0.96), uncontrolled systolic blood pressure (OR=0.94; 95 % CI; 0.90-0.99) and uncontrolled diastolic blood pressure (OR=0.92; 95 % CI; 0.87- 0.97) compared to patients with lower socioeconomic scores. Higher amounts of fasting blood sugar, HbA1c, systolic and diastolic blood pressure were correlated with higher SES scores among diabetic patients in linear regression analyses (FBS coefficient = -2.23, HbA1c coefficient= -0.079 , systolic & diastolic blood pressure coefficient= -0.39 and -0.17).
Conclusions: Low socioeconomic status assessed in this Iranian population was associated with higher odds of cardiovascular risk factors predisposing to poor consequences among diabetic patients with low socioeconomic status.
Hattersley L. Trends in life expectancy by social class: An Update. Health Statistics Q 1999. 2: 16-24.
Marmot MG,Stanfield S,Patel C,North F,Head J,White I et al. Health inequities among British civil servants: The Whitehall II study. Lancet 1991. 337: 1387-1393.
Winkelby M, Cubbin C, Influence of individual and neighborhood socioeconomic status on mortality among black, Mexican- American and white women and men in the United States. Journal of Epidemiology and Community Health 2003. 57: 444-452.
Amos AF,McCarty DJ, Zimmet P, The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic medicine 1997. 14: S7–85.
World Health organization.Diabetes.(fact sheet No 312)WHO 2013
Haghdoost A.A,Rezazadeh-Kermani M,Sadghirad BBaradaran H.R, Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J 2009. 15: 591-599.
Stelmach W,Kaczmarczyk-Chalas K,Bielecki W,Drygas W, How education, income, control over life and lifestyle contribute to cardiovascular risk factors in adults in a post-communist country. J Public Health 2005. 119: 498-508.
Howard JA,Bower KPutnam W, Factors Influencing the Management of Hypertension in Type 2 Diabetes. CANADIAN JOURNAL OF DIABETES 2006. 30: 38-45.
United Kingdom Prospective Diabetes Study Group. UK prospective diabetes study:intensive blood glucose control with sulphony- lureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998. 352: 837–853.
Bachmann MO,Eachus J,Hopper CD,Smith GD,Propper C,Pearson NJ et al. Socio-economic inequalities in diabetes complications, control, attitudes and health service use:a cross-sectional study. Diabet Med 2003. 20: 921-929.
Roper NA,Ballous RW,Kelly WF,Unwin NC,Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001. 322: 1375-1376.
Albala BB, Cammack S, Chong J,Wang C,Wright C,Rundek T et al. Diabetes, Fasting Glucose Levels, and Risk of Ischemic Stroke and Vascular Events: Findings from the Northern Manhattan Study (NOMAS).Diabetes Care 2008. 31: 1132- 1137.
The CDC Diabetes Cost - effectiveness Group: Cost - effectiveness of intensive glycemic control,intensified hypertension and serum cholestrol level reduction for type 2 diabetes JAMA 2002.287:2542-2551
Bachmann MO,Eachus J,Hopper CD,Davey Smith G,Propper C,Pearson NJ et al. Socio-economic inequalities in diabetes complications, control, attitudes and health service use: a cross-sectional study. Diabetic Medicine 2003. 20: 921–929.
Gallegos-Maciasa AR,Maciasa SR,Kaufmanb E,Skippera BKalishman N, Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus. Pediatric Diabetes 2003. 4: 19-23.
Dennis r,Anstice S,Raine K,McGannon KR,Rizivi SKYu V, The social determinants of the incidence and management of type 2 diabetes mellitus :are we prepared to rethink our questions and redirect our research activities? International Journal of Health Care Quality Assurance incorporateing leadership in health Services 2003. 16: x-xx.
Robbins JM,Vaccarino V,Zhang HK. SV, Socioeconomic Status and Type2 Diabetes in African american and Non-Hispanic White Women and Men:Evidence from the Third National Health and Nutriton Examination Suryey. Am J Public Health 2001. 91: 76-83.
Brown AF,Ettner SL,Piette J,Weinberger M,Gregg E,Shapiro MF et al. Socioeconomic Position and Health among Persons with Diabetes Mellitus:A Conceptual Framework and Review of the Literature. Epidemiol Rev 2004. 26: 63-77.
McKinlay JMarceau L, US public health and the 21st century:diabetes mellitus 2000. 356: 757–761.
Booth GL Hux JE Relationship between avoidable hospitalizations for diabetes mellitus and income level. Archives of Internal Medicine 2003. 163: 101-106.
Gnavi R, Petrelli A,Demaria M,Spadea T,Carta Q,Costa G:Mortality and educational level among diabetic and nondiabetic population in the Turine longitional study:a 9-year follow up.Int J Epidemiol 2004.33:864-871.
Tajik P, Nedjat S, Emami Afshar N, Changizi N, Yazdizadeh B, Azemikhah A etal. Inequality in Maternal Mortality in Iran: An Ecologic Study, Int J Prev Med 2012. 3(2): 116–121.
Hosseinpoor AH, Kazem Mohammad, Majdzadeh R, Naghavi M, Abolhassani F, Sousa A et al, Socioeconomic inequality in infant mortality in Iran and across its provinces, Bulletin of the World Health Organization 2005;83:837-844.
Hosseinpoor AR, BergenN, Kunst A , Harper S, Guthold R , Rekve D etal. Socioeconomic inequalities in risk factors for non communicable diseases in low-income and middle-income countries: results from the World Health Survey,BMC public Health 2012 12;912.
Ebrahimi M, Mansournia MA, Haghdoost AA, Abazari A, Alaeddini F, Mirzazadeh A et al. Social disparities in prevalence, treatment and control of hypertension in Iran: Second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006. Journal of Hypertension 2010. 28(8):1620-1629.
Afukaar, F. K, Antwi, P,Ofosu-Amaah, S. Pattern of road traffic injuries in Ghana: implications for control. Inj Control Saf Promot 2003 ;10(1-2):69-76
Hasselberg M, Vaez M, Laflamme L. Socioeconomic aspects of the circumstances and consequences of car crashes among young adults. Soc Sci Med. 2005 ;60(2):287-95.
James GD, Baker P, Badrick E, Mathur R, Hull S, Robson J. Ethnic and social disparity in glycaemic control in type 2 diabetes; cohort study in general practice 2004-9. J R Soc Med. 2012;105(7):300-8.
OkaneMJ,McMenaminM,BuntingBP,MooreA,CoatesVE. The relationship between socioeconomic status deprivation and metabolic /cardiovascular riskfactors in a cohort of patients with type 2 diabetes mellitus. Prim Care diabetes,2010 4(4):241-9
Edwards R, Burns JA, McElduff P, Young RJ, Variations in process and outcomes of diabetes care by socio-economic status in Salford, UK.New JP Diabetologia. 2003 Jun;46(6):750-9. Epub 2003 May 23.
Gakidou E, Mallinger L, Abbott-Klafter J, Guerrero R, Villalpando S, Ridaura RL et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89(3):172-83
Bäz L, Müller N, Beluchin E, Kloos C, Lehmann T, Wolf G et al. Differences in the quality of diabetes care caused by social inequalities disappear after treatment and education in a tertiary care centre. Diabet Med. 2012;29(5):640-5.